The latest clinical guidelines from the American College of Gastroenterology aim to improve the diagnosis and treatment of ...

Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the <a target=_blank href=https:// ...

Everest Medicines announces the implementation of Nefecon NRDL pricing in China for the treatment for IgA nephropathy: Shanghai, China Saturday, January 4, 2025, 10:00 Hrs [IST] E ...

The US regulator has cleared Eohilia (formerly TAK-721), an oral suspension formulation of the well-established steroid drug budesonide, for people 11 years and older with EoE after turning down ...

The drug – already granted accelerated approval ... at a discount to Calliditas’ corticosteroid-based Tarpeyo (budesonide) therapy, which became the first FDA-approved therapy for IgAN in ...

Let’s look specifically at dexamethasone, a common corticosteroid in emergency medicine, and use current research to describe what the drug does ... like budesonide, have different indications ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

Budesonide is a synthetic steroid with a 15-fold higher affinity for glucocorticoid receptors. It is an alternative to prednisolone. Due to its high first-pass metabolism in the liver, budesonide ...

The conventional therapy consists of a sequential ('step-up') approach with an initial treatment with budesonide or prednisone, followed by azathioprine if patients became steroid-dependant or ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...

improved antibody internalization and enhanced the cytotoxicity of a HER2-targeting antibody drug conjugate.